-
1دورية أكاديمية
المؤلفون: Ratner, ES, Keane, FK, Lindner, R, Tassi, RA, Paranjape, T, Glasgow, M, Nallur, S, Deng, Y, Lu, L, Steele, L, Sand, S, Muller, R-U, Bignotti, E, Bellone, S, Boeke, M, Yao, X, Pecorelli, S, Ravaggi, A, Katsaros, D, Zelterman, D, Cristea, MC, Yu, H, Rutherford, TJ, Weitzel, JN, Neuhausen, SL, Schwartz, PE, Slack, FJ, Santin, AD, Weidhaas, JB
المصدر: Oncogene. 31(42)
مصطلحات موضوعية: Ovarian Cancer, Genetics, Rare Diseases, Clinical Research, Cancer, 2.1 Biological and endogenous factors, Aetiology, 3' Untranslated Regions, Aged, Antineoplastic Combined Chemotherapy Protocols, BRCA1 Protein, BRCA2 Protein, Biomarkers, Tumor, Carboplatin, Cell Line, Tumor, Cell Survival, Drug Resistance, Neoplasm, Female, Genotype, Humans, Kaplan-Meier Estimate, Middle Aged, Multivariate Analysis, Mutation, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Paclitaxel, Polymorphism, Single Nucleotide, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), RNA Interference, Treatment Outcome, ras Proteins, platinum resistance, KRAS variant, ovarian cancer, outcome, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/6n55m2gzTest
-
2دورية أكاديمية
المؤلفون: Ratner ES, Keane FK, Lindner R, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Boeke M, Yao X, Katsaros D, Zelterman D, Cristea MC, Yu H, Rutherford TJ, Weitzel JN, Neuhausen SL, Schwartz PE, Slack FJ, Santin AD, Weidhaas J.B., TASSI, Renata Alessandra, BIGNOTTI, Eliana, BELLONE, Stefania, PECORELLI, Sergio, RAVAGGI, Antonella
المساهمون: Ratner, E, Keane, Fk, Lindner, R, Tassi, Renata Alessandra, Paranjape, T, Glasgow, M, Nallur, S, Deng, Y, Lu, L, Steele, L, Sand, S, Muller, Ru, Bignotti, Eliana, Bellone, Stefania, Boeke, M, Yao, X, Pecorelli, Sergio, Ravaggi, Antonella, Katsaros, D, Zelterman, D, Cristea, Mc, Yu, H, Rutherford, Tj, Weitzel, Jn, Neuhausen, Sl, Schwartz, Pe, Slack, Fj, Santin, Ad, Weidhaas, J. B.
مصطلحات موضوعية: kra, platinum chemotherapy
العلاقة: volume:UNICO; firstpage:_; lastpage:_; journal:ONCOGENE; http://hdl.handle.net/11379/112913Test
-
3دورية أكاديمية
المؤلفون: Paranjape, T, Heneghan, H, Lindner, R, Keane, FK, Hoffman, A, Hollestelle, Antoinette, Dorairaj, J, Geyda, K, Pelletier, C, Nallur, S, Martens, John, Hooning, Maartje, Kerin, M, Zelterman, D, Zhu, Xiaoye, Tuck, D, Harris, L, Miller, N, Slack, F, Weidhaas, J
المصدر: Paranjape , T , Heneghan , H , Lindner , R , Keane , FK , Hoffman , A , Hollestelle , A , Dorairaj , J , Geyda , K , Pelletier , C , Nallur , S , Martens , J , Hooning , M , Kerin , M , Zelterman , D , Zhu , X , Tuck , D , Harris , L , Miller , N , Slack , F & Weidhaas , J 2011 , ' A 3 '-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis ' , ....
مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, SDG 3 - Good Health and Well-being
الإتاحة: https://doi.org/10.1016/S1470-2045Test(11)70044-4
https://pure.eur.nl/en/publications/516afa1a-fb09-4ea9-b62e-233dd8a1cc2bTest
http://hdl.handle.net/1765/25549Test